Tonix Pharmaceuticals Holdin

Biotech Stocks Healthcare Stocks

$14.28

+0.53 (+3.85%)

As of Apr 1, 2:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +185.3% upside

Low Target $28.14

Average Target $40.74

High Target $50.62

Current Price $14.28

Current
$14.28

Target
$40.74

$28.14 $40.74 avg $50.62

Scenario Analysis

Bear Case

$28.14

97.1%

Low target

Base Case

$40.74

+185.3%

Avg target

Bull Case

$50.62

+254.5%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$44.54

-67.9% from high

52-Week Low

$30.30

+-52.9% from low

Target vs 52W High

$40.74

-8.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%